Related Experiment Video
Updated: Oct 2, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
Proton Therapy for Prostate Cancer: Challenges and Opportunities
Darren M C Poon1, Stephen Wu2, Leon Ho2
1Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, Hong Kong 999077, China.
Cancers
|February 25, 2022
Summary
Proton therapy (PT) offers dosimetric advantages for prostate cancer over photon therapy, but similar outcomes suggest issues with dose delivery. New technologies aim to improve PT accuracy and conformity for better clinical results.
Area of Science:
- Radiation Oncology
- Medical Physics
- Oncology
Background:
- Proton therapy (PT) demonstrates superior dosimetric advantages over photon-based external beam radiotherapy (EBRT) for localized prostate cancer.
- However, similar clinical outcomes between PT and EBRT suggest potential issues in dose prescription or delivery accuracy.
- Uncertainties in treatment planning and delivery can compromise the dose conformity of PT, potentially limiting its clinical benefits.
Purpose of the Study:
- To review the challenges in proton therapy for prostate cancer and highlight emerging technologies to address them.
- To explore how advanced PT techniques can improve treatment accuracy, dose conformity, and clinical outcomes.
- To discuss the potential for dose escalation and hypofractionation with improved PT precision.
Main Methods:
- Review of advanced PT technologies and techniques for improving accuracy and dose conformity.
- Discussion of innovations in patient positioning (e.g., MRI-guidance), beam delivery (high-dose rate), and treatment verification (e.g., prompt gamma detectors).
- Examination of advanced treatment planning systems (e.g., dual-energy photon-counting CT, Monte Carlo simulations).
Main Results:
- Emerging PT technologies aim to minimize geometric and dosimetric uncertainties.
- In-room MRI-guided systems and high-dose rate delivery promise enhanced accuracy and reduced motion artifacts.
- Advanced planning and verification tools are expected to improve dose calculations and in-vivo accuracy.
Conclusions:
- Clinical implementation of advanced PT technologies is anticipated to improve accuracy and dose conformity for prostate cancer treatment.
- Enhanced precision may enable dose escalation, improving local control and facilitating hypofractionation.
- These advancements could lead to better clinical outcomes and make PT more cost-effective.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K